EDGAR Filing Documents for 0001493152-21-000336

Form 8-K - Current report:

SEC Accession No. 0001493152-21-000336

Filing Date

2021-01-06

Accepted

2021-01-06 17:10:20

Documents

Period of Report

2020-12-30

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm	8-K	148687
2		ex3-1.htm	EX-3.1	29911
3		ex3-2.htm	EX-3.2	14550
4		ex3-3.htm	EX-3.3	99879
5		ex3-4.htm	EX-3.4	214446
6		ex10-1.htm	EX-10.1	77160
7		ex10-2.htm	EX-10.2	72445
8		ex10-3.htm	EX-10.3	71958
9		ex10-4.htm	EX-10.4	24097
10		ex10-5.htm	EX-10.5	167905
11		ex10-6.htm	EX-10.6	58304
12		ex99-1.htm	EX-99.1	28338
13		ex99-2.htm	EX-99.2	15196
14		ex99-1_001.jpg	GRAPHIC	9427
	Complete submission text file	0001493152-21-000336.txt		1037841

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103

Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707

Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)